Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
APPY: Stock Quote & Summary Data
1.2%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | N/A |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 116,506 |
| Previous Close | $ 1.68 |
| 52 Wk High / Low | $ 7.78 / $ 1.045 |
| Shares Outstanding | 37,468,000 |
| Market Value | $ 62,193,133.20 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.58 |
| NASDAQ Official Open Price: | $ 1.68 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 1.66 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About APPY?
Ask your question about about AspenBio Pharma, Inc. (APPY) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
AspenBio Pharma, Inc. (the “Company” or “AspenBio” also we, us or our) is an emerging medical biotechnology company engaged in the discovery, research, development, manufacture, and licensing or marketing of novel drugs and diagnostics for human and animal healthcare. Founded in August 2000, as a Colorado corporation and headquartered in Castle Rock, Colorado, we leverage our proprietary knowledge and technology towards the development of novel patented or patentable products we believe have substantial market potential. Using our proprietary protein purifying methods and other proteomic technologies, we discovered several blood markers that appear to correlate with appendicitis in humans. We are currently engaged in the development and testing of our two first-generation blood-based human diagnostic tests designed to rapidly help screen or rule out appendicitis in patients complaining of abdominal pain. ... More ...
Links to all AspenBio Pharma, Inc. (APPY) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for APPY |
||
|
AspenBio to Present at the Lazard Capital Market 6th Annual Healthcare Conference - Market Wire 11/13/2009 11:45AM |
||
|
AspenBio Pharma Appoints Andrew Peters As VP, Animal Health - Quick Facts - RTT News 10/14/2009 10:18AM |
||
|
AspenBio Pharma Fills Key Animal Health and Quality Leadership Positions - Market Wire 10/14/2009 8:30AM |
||
|
AspenBio Pharma Announces Closing of Public Offering of 5,155,000 Common Shares - Market Wire 10/14/2009 7:30AM |
||
|
AspenBio Pharma Prices 4.48 Mln Common Shares At $1.70 Per Share - Quick Facts - RTT News 10/07/2009 7:45AM |
||
|
AspenBio Pharma Announces Public Offering of 4,482,609 Common Shares - Market Wire 10/07/2009 7:30AM |
||
|
The Next Million-Dollar Penny Stock - The Motley Fool 10/05/2009 2:46PM |
